Table 2 Target volume and dose concept depending upon stage, grading and PSA
Low risk: white | Medium risk: light grey | High risk: dark grey | |
|---|---|---|---|
Stage | ≤ cT2a | ≤ cT2c | cT3 |
PSA | ≤ 10 | < 20 | < 20 |
G 1 Gleason 2–3 | Prostate | Prostate & base of seminal vesicles 70 Gy | Prostate & base of seminal vesicles & visible tumour 74 Gy |
G 2 Gleason 4–6 | Prostate | Prostate & base of seminal vesicles 70 Gy | Prostate & base of seminal vesicles & visible tumour 74 Gy |
G 3 Gleason > 6 | Prostate & base of seminal vesicles 70 Gy | Prostate & base of seminal vesicles 70 Gy | Prostate & base of seminal vesicles & visible tumour 74 Gy |